4//SEC Filing
Torley Helen 4
Accession 0001159036-25-000073
CIK 0001159036other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 6:16 PM ET
Size
6.3 KB
Accession
0001159036-25-000073
Insider Transaction Report
Form 4
Torley Helen
DirectorPresident and CEO
Transactions
- Award
Performance Stock Units
2025-12-09+165,522→ 165,522 totalExercise: $0.00→ Common Stock (165,522 underlying)
Footnotes (1)
- [F1]Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement).
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001528185
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 6:16 PM ET
- Size
- 6.3 KB